Centers must register new patients in FormsNet3 within 30 days of their first infusion.
Reporting Requirements
US Centers
The US Government requires all US Centers to report allogeneic related and unrelated donor HCTs performed at their center, regardless of patient consent. Additionally, if a center chooses to report autologous HCTs to the CIBMTR, then all autologous HCTs must be reported.
International Centers
International centers must comply with their governing body’s requirements for data sharing to CIBMTR. Only centers with appropriate data sharing and research consent should report to CIBMTR.
Additional Reporting Resources
- Determining Reporting Levels: US Centers
- Determining Reporting Levels: International Centers
- For center reporting preferences or updating preferences, submit a CIBMTR Center Support ticket. Select “What is your question regarding?” = CIBMTR Center Maintenance, and “Relating to:” = Change Reporting Track”
Process for Reporting Infusions in FormsNet3
For a patient’s first infusion, complete the following:
- Register the patient in FormsNet3 by completing a CRID Assignment Tool (2804) form
- Submit an Indication for CRID Assignment (2814) form
- Provide the patient’s consent for research in the Consent Tool
- Submit the Pre-TED (2400) form
For subsequent infusions (for the same patient), complete the following:
- Complete the follow-up (2450, 2100, or 4100) form for the prior infusion; report the date of the subsequent infusion.
- NOTE: If no follow-up forms exist for the prior infusion, an Indication for CRID Assignment (2814) form can be made due by selecting “Create Indication Form” after pulling up the CRID on the Recipient Forms page in FormsNet3.
- Submit the Pre-TED (2400) form
Last modified:
Mar 08, 2024